| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.8B | $30.5B | $29.5B | $27.8B | $25.6B | $20.4B | $5.9B | $5.4B |
| Cost of Revenue | $26.6B | $25.4B | $24.6B | $23.0B | $21.1B | $17.3B | $19.7B | $19.4B |
| Gross Profit | $1.2B | $5.0B | $4.9B | $4.8B | $4.4B | $3.2B | $0.9B | $0.8B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.8B | $3.5B | $3.4B | $3.2B | $3.0B | $2.4B | $2.7B | $2.6B |
| Operating Income | $1.3B | $1.3B | $1.4B | $1.5B | $1.4B | $0.7B | $0.7B | $0.7B |
| Net Income | $0.2B | $0.9B | $1.1B | $1.4B | $1.2B | $0.5B | $0.1B | $0.1B |
| EPS (Basic) | $2.83 | $13.74 | $15.50 | $18.55 | $14.89 | $6.74 | $5.28 | $5.53 |
| EPS (Diluted) | $2.83 | $13.74 | $15.50 | $18.55 | $14.89 | $6.74 | $1.25 | $1.16 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $17.6B | $16.7B | $15.7B | $14.1B | $13.5B | $13.2B | $13.9B | $10.9B |
| Current Assets | $6.2B | $5.9B | $5.7B | $4.7B | $4.1B | $4.4B | $5.3B | $5.1B |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $12.0B | $11.5B | $10.9B | $9.9B | $9.4B | $9.9B | $11.1B | $8.3B |
| Current Liabilities | $6.3B | $6.5B | $5.7B | $4.7B | $4.3B | $4.7B | $5.5B | $5.0B |
| Stockholders' Equity | $5.6B | $5.2B | $4.7B | $4.1B | $4.1B | $3.3B | $2.8B | $2.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $1.2B | — | — | — | — | — | — |
| Investing Cash Flow | $-0.2B | $-1.0B | $-0.6B | $-0.6B | $-0.6B | — | — | — |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.8B | $-0.2B | $-0.5B | $-0.8B | $-0.6B | — | — | — |